![](/img/cover-not-exists.png)
[Lupus Foundation of America 12th European Lupus Meeting - ()] Poster presentations - P132â Design of an adaptive, phase 2, placebo-controlled, dose-ranging study to assess the efficacy and safety of AMG 570 in subjects with active SLE and inadequate response to standard of care therapy
Zhou, Lei, Wang, Hui, Jiang, Tony, Garces, Sandra, Cheng, Laurence E, Lenz, Rob, Kaur, PrimalDOI:
10.1136/lupus-2020-eurolupus.176
File:
PDF, 84 KB